Michael Newman Net Worth & Insider Trades

Michael Newman - CSO and Director, Indaptus Therapeutics, Inc

As of February 2, 2022

What is Michael Newman's Net Worth?

The current estimated net worth of Indaptus Therapeutics, Inc's CSO and Director, Michael Newman, is estimated to be about $3.71M . Michael Newman owns about 1,368,356 units of Indaptus Therapeutics, Inc common stock. In the last year at Indaptus Therapeutics, Inc, Michael Newman has sold an estimated value of $100.04K worth.

What is Michael Newman's Past Insider Trading?

Michael Newman's largest sale order was 20,000 units , worth over $100.04K on February 2, 2022. In total, Michael Newman has made about 3 transactions over a year of their time at Indaptus Therapeutics, Inc. Michael Newman usually trades in February, August and January, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Michael Newman's' Mailing Address?

  • Mailing address is C/o Intec Parent, Inc. 12 Hartom St., Har Hotzvim Jerusalem L3 9777512 Israel

What are Indaptus Therapeutics, Inc's Past Insider Trades?

Indaptus Therapeutics, Inc's most recent insider trade came on September 12, 2022 by Jeffrey Meckler who bought 10,308 units worth $28.86K . In the last year, insiders at Indaptus Therapeutics, Inc have sold an estimated value of $100.04K and bought an estimated value of $255.02K worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Jeffrey Meckler, CEO and Director,  Michael Newman, CSO and Director,  and Walt Linscott, Chief Business Officer .

Indaptus Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1